NYMXF

Nymox Pharmaceutical Corp.

NYMXF·P73398102·US·Common Stock·Healthcare - Biotechnology

NYMXF (Nymox Pharmaceutical Corp.) is held by 0 institutional investors as of Q3 2023. Net institutional sentiment: Bearish.

0
Holders
Avg rating(4 Elite)
$0
Total Value
0% (14)
Fund Consensus
0 buying - 14 selling

No verdict yet — fewer than 2 funds hold NYMXF.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Exited
0(-100.0%)$1,0080.0%+41.05%
0
Exited
0(-100.0%)$1630.0%-76.16%
0
Exited
0(-100.0%)$7,9640.0%-57.84%
0
Exited
0(-100.0%)$3,8760.0%-51.06%
0
Exited
0(-100.0%)$38,1900.0%-63.40%
0
Exited
0(-100.0%)$2,1910.0%-80.00%
0
Exited
0(-100.0%)$4,7500.0%+62.50%
0
Exited
0(-100.0%)$3,2650.0%-45.26%
0
Exited
0(-100.0%)$4,0000.0%+82.21%
0
Exited
0(-100.0%)$12,0000.0%+62.50%
0
Exited
0(-100.0%)$5,3200.0%+40.54%
0
Exited
0(-100.0%)$9,6280.0%-82.66%
0
Exited
0(-100.0%)$4,7580.0%+62.50%
0
Exited
0(-100.0%)$6,5600.0%+120.87%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used